Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

linifanib MeSH Supplementary Concept Data 2025


MeSH Supplementary
linifanib
Unique ID
C513486
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C513486
Entry Term(s)
1-(4-(3-amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea
A 741439
A-741439
A741439
ABT 869
ABT-869
ABT869
N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
RG 3635
RG-3635
RG3635
Registry Numbers
CO93X137CW
0
Heading Mapped to
*Indazoles
*Phenylurea Compounds
Frequency
55
Note
has antineoplastic activity
Source
Mol Cancer Ther 2006 Apr;5(4):995-1006
Indexing Information
Receptor Protein-Tyrosine Kinases
Date of Entry
2006/09/17
Revision Date
2022/06/01
linifanib Preferred
ABT 869 Narrower
A 741439 Narrower
RG 3635 Narrower
page delivered in 0.007s